Advertisement
At the 2008 ASH Annual Meeting, Clara D. Bloomfield, M.D., of the Ohio State University in Columbus, OH, will be presented with the Henry M. Stratton Medal, intended to honor an individual whose well-recognized contributions to hematology have taken place over a period of several years. Dr. Bloomfield will receive this award for her remarkable achievements in the area of hematologic malignancies, especially acute myelogenous leukemia, for more than three decades. Dr Bloomfield has been a major contributor to the understanding of the biology of these diseases and the practical use of biologic information in diagnosis, classification, and determining prognosis and selection of curative therapeutic approaches.
Advertisement
Kenneth Anderson, M.D., of the Dana-Farber Cancer Institute in Boston, MA, will be presented with the William Dameshek Prize, awarded to an individual who has made a recent outstanding contribution to the field. Dr. Anderson will be recognized for his contributions to the treatment of myeloma. He has advanced the field by establishing a new paradigm focused not only on the malignant cell, but also on the microenvironment for the identification of molecularly-targeted therapies. His rapid translations of his pre-clinical discoveries into phase I-III trials have substantially improved the clinical outcome for myeloma patients.
Robert Kyle, M.D., of the Mayo Clinic in Rochester, MN, will be presented with the Wallace H. Coulter Award for Lifetime Achievement in Hematology, which was established in 2007 to honor individuals who have made a lifelong commitment to the specialty and whose contributions have had a major impact on education, research, and/or practice. Dr. Kyle will receive the award for his contributions to the study of multiple myeloma, monoclonal gammopathies, amyloidosis, and related plasma-cell disorders. Throughout his 50-year career as a physician-researcher, educator, and consultant, he has focused on defining these diseases, understanding their pathogenesis, presentation, and prognosis, and designing and evaluating therapeutic approaches. In addition, he has authored more than a thousand publications has trained more than 200 practicing hematologists.
These awards are named after notable figures in the Society's history and will be awarded during the 50th ASH Annual Meeting in December at the Moscone Center in San Francisco. Dr. Kyle will be presented with his award prior to the Plenary Scientific Session on Sunday, December 7, at 1:30 p.m. EST. Drs. Bloomfield and Anderson will be presented with their awards at the Presidential Symposium to be held on Tuesday, December 9, at 9:30 a.m. For the complete annual meeting schedule and additional information, please visit http://www.hematology.org/meetings/2008.
The American Society of Hematology (www.hematology.org) is the world's largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology.
SOURCE American Society of Hematology
